To provide the information your oncologist is not telling you or doesn't have the time to!
Hello, MedOncMD.com readers! This week is Mental Health Week, and I want to extend a special shoutout to our mental health professionals. In the field of oncology, we recognize the importance of mental health. The diagnosis of cancer is often a shocking and emotionally challenging experience. It can have a profound impact on individuals, both …
Blood clotting is a vital survival mechanism. When we experience injuries like cuts or scrapes, our body employs a complex and organized process to prevent excessive bleeding. Here’s how it works: Platelet Response: Damaged tissues send signals into the bloodstream, prompting platelets to rush to the injury site. These platelets start plugging the wound. Coagulation …
Breast cancer, a formidable adversary, affects millions of lives worldwide each year. In our quest to combat this disease, knowledge is the most potent weapon we have. Breast Cancer Awareness Month is the ideal time to explore the intricacies of breast cancer risk factors, from the genetic underpinnings to lifestyle choices that can influence your …
I just spent a very busy month on the inpatient medical oncology service and thought I would share some insight about what medical oncologist see and do in-house. Navigating the healthcare system can often feel like a maze, particularly when a loved one is admitted to the hospital and under the care of multiple specialists. …
Myeloproliferative disorders are a group of conditions characterized by overactivity in the bone marrow. Many of these conditions are driven by mutations in the JAK-2 gene (Janus Kinase 2 gene), which plays a crucial role in regulating the growth and production of cells in the bone marrow. While there are other mutations involved, JAK-2 mutations …
Traditional Treatment Approaches for Hodgkin’s Lymphoma Lymphomas encompass a diverse group of blood cancers, with various types and treatment approaches depending on factors such as lymphoma subtype, origin, and aggressiveness. One particular lymphoma subtype with unique treatment options is Hodgkin’s lymphoma. Traditionally, in the United States, Hodgkin’s lymphoma has been treated with a chemotherapy combination …
We are currently in an era where we’re shifting from traditional chemotherapies to leveraging the body’s immune system. CAR-T and bispecific antibodies are two innovative approaches to achieve this.
In the realm of oncology trials, we employ a severity rating system known as the Grade scale to assess toxicities. This scale helps us gauge whether a patient should modify or discontinue their treatment. The Grade scale consists of five points, ranging from mild toxicities to life-threatening ones.
Uveal melanoma, a rare and aggressive form of eye cancer, has just witnessed a groundbreaking development in its treatment landscape. The Food and Drug Administration (FDA) recently granted approval to the HEPZATO KIT, an innovative liver-directed therapy that offers new hope to adult patients with uveal melanoma and unresectable hepatic metastases.
The choice to participate in a clinical trial may sound scary or it may sound exciting but if you are considering it, the real question is what happens next? Below I will help you navigate through the process of getting onto a clinical trial by answering some of the questions that I get from patients who are going through this process.